Moderna, Inc. (MRNA) reporting calendar
Moderna, Inc. files periodic reports with the SEC as MRNA on Nasdaq. Atlas tracks 21 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 24 Jul 2026 – 13 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 1 May 2026
- Reports on record
- 21
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 34 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open MRNA market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 1 May 2026 | 31 days | 0001682852-26-000060 |
| 10-K | 31 Dec 2025 | 20 Feb 2026 | 51 days | 0001682852-26-000033 |
| 10-Q | 30 Sep 2025 | 6 Nov 2025 | 37 days | 0001682852-25-000075 |
| 10-Q | 30 Jun 2025 | 1 Aug 2025 | 32 days | 0001682852-25-000044 |
| 10-Q | 31 Mar 2025 | 1 May 2025 | 31 days | 0001682852-25-000034 |
| 10-K | 31 Dec 2024 | 21 Feb 2025 | 52 days | 0001682852-25-000022 |
| 10-Q | 30 Sep 2024 | 7 Nov 2024 | 38 days | 0001682852-24-000060 |
| 10-Q | 30 Jun 2024 | 1 Aug 2024 | 32 days | 0001682852-24-000046 |
| 10-Q | 31 Mar 2024 | 2 May 2024 | 32 days | 0001682852-24-000027 |
| 10-K | 31 Dec 2023 | 23 Feb 2024 | 54 days | 0001682852-24-000015 |
| 10-Q | 30 Sep 2023 | 3 Nov 2023 | 34 days | 0001682852-23-000042 |
| 10-Q | 30 Jun 2023 | 3 Aug 2023 | 34 days | 0001682852-23-000027 |
| 10-Q | 31 Mar 2023 | 4 May 2023 | 34 days | 0001682852-23-000021 |
| 10-K | 31 Dec 2022 | 24 Feb 2023 | 55 days | 0001682852-23-000011 |
| 10-Q | 30 Sep 2022 | 3 Nov 2022 | 34 days | 0001682852-22-000051 |
| 10-Q | 30 Jun 2022 | 3 Aug 2022 | 34 days | 0001682852-22-000042 |
| 10-Q | 31 Mar 2022 | 4 May 2022 | 34 days | 0001682852-22-000025 |
| 10-K | 31 Dec 2021 | 25 Feb 2022 | 56 days | 0001682852-22-000012 |
| 10-Q | 30 Sep 2021 | 4 Nov 2021 | 35 days | 0001682852-21-000027 |
| 10-Q | 30 Jun 2021 | 5 Aug 2021 | 36 days | 0001682852-21-000022 |
| 10-Q | 31 Mar 2021 | 6 May 2021 | 36 days | 0001682852-21-000017 |
Source: SEC EDGAR company submissions for CIK 0001682852. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.